India's SeQuent Scientific up on EU GMP approval for manufacturing in Turkey

Viyash Scientific

15/07/2021 07:33

** Carlyle-backed Indian animal healthcare co's  SEQU.NS 
shares gain as much as 7.8% to 288.50
    ** SEQU said on Wednesday it received the European Union
Good Manufacturing Practice (EU GMP) approval for its tablets
dosage manufacturing line in Turkey  urn:newsml:reuters.com:*:nFWN2OQ0QH
    ** The EU GMP describes the minimum standard that a
medicines manufacturer must meet in their production processes
    ** SEQU says it also got renewal of EU GMP license for eight
other manufacturing lines for various dosage forms in Turkey 
    ** Co says https://bit.ly/2VL0qkv it is the third-largest
player in the Turkish ruminant market with a consolidated market
share of about 10% 
    ** Up to Wednesday's close, stock had risen 57.8% YTD


 (Reporting by Anuron Kumar Mitra in Bengaluru)
 ((AnuronKumar.Mitra@thomsonreuters.com; +91 99863 58469;))